An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

Local Institution - 336, Sayama

Local Institution - 338, Matsuyama

Local Institution - 344, Nagasaki

Local Institution - 345, Chiba

Local Institution - 334, Fukuoka

Local Institution - 347, Himeji

Local Institution - 337, Hitachi, Ibaraki

Local Institution - 346, Kamakura

Local Institution - 331, Kamogawa

Local Institution - 348, Kitakyushu

Local Institution - 349, Kofu

Local Institution - 343, Nagoya

Local Institution - 335, Okayama

Local Institution - 342, Osaka

Local Institution - 341, Ōgaki

Local Institution - 333, Sagamihara

Local Institution - 339, Sendai

Local Institution - 332, Shibuya-ku

Local Institution - 330, Shinagawa-ku, Tokyo